Genomics Education explores a new gene therapy treatment that aims to cross the blood-brain barrier in the treatment of Hunter syndrome.
Hunter syndrome is a rare genetic condition, belonging to a wider group of lysosomal storage diseases. The UK Medicines and Healthcare Products Regulatory Agency has now approved a two-year trial in a world's first.
Read more here.
